Click here for French version
Prof. Dr. Frank Stangenberg Haverkamp, Chairman of the Executive Board of E. Merck KG and the Chairman of Merck Foundation Board of Trustees, H.E. FAUSTIN-ARCHANGE TOUADÉRA, The President of Central African Republic and Dr. Rasha Kelej, CEO of Merck Foundation
Merck Foundation, the philanthropic arm of Merck Germany underscored their commitment to build healthcare capacity in Central African Republic- C.A.R. during their high level meeting with The Head of State , H.E. FAUSTIN-ARCHANGE TOUADÉRA. The discussion led by Prof. Dr. Frank Stangenberg Haverkamp, Chairman of the Executive Board of E. Merck KG and the Chairman of Merck Foundation Board of Trustees and Dr. Rasha Kelej, CEO of Merck Foundation to explain and discuss the programs which launched on the same day in partnership with The First Lady and ministry of Health of C.A.R.
H.E. FAUSTIN-ARCHANGE TOUADÉRA, the President of Central African Republic emphasized “Central African Republic needs the programs of Merck Foundation urgently. These training programs for specialized doctors are very critical for our people and their social and economic well-being. I wholeheartedly support Merck Foundation in our country, to enable the success of all their programs.”
“Through Merck Foundation, we commit to the long term partnership with Ministry of Health and The first Lady foundation to build healthcare capacity in the country “Prof. Dr. Frank Stangenberg-Haverkamp explained.
“I am very happy and proud to organize this meeting. This partnership will help us train specialized doctors in the fields of Diabetes, Hypertension, Oncology and Infertility care. This will help to contribute significantly towards social and economic development in Central African Republic. We are committed to lead Africa to a better future through changing the landscape of healthcare in the continent with special focus on French speaking countries in the next few years”, emphasized Dr. Rasha Kelej,
Merck Foundation together with H.E. MADAM BRIGITTE TOUADERA, The First Lady of Central African Republic & Merck more than a Mother Ambassador have conducted a special meeting with more than 100 infertile women who have been enrolled in the “Empowering Berna” project to establish small businesses and train them to be able to generate steady monthly income. Dr. Rasha Kelej, President of Merck more than a Mother has pledged to support more childless women through Merck more than a Mother campaign. In partnership with the First Lady and ministry of health, Merck foundation will provide clinical training on fertility specialty to improve access to quality and equitable fertility care in the country.
H.E. Madam BRIGITTE TOUADERA, The First Lady of Central African Republic and Dr. Rasha Kelej, CEO of Merck Foundation meeting Infertile Women.
Merck foundation have also approved a list of candidates to be enrolled in their one and two year oncology fellowship program as a contribution to improve cancer care in the country. Moreover, they will also provide on-line diabetes diplomas in French for Doctors from C.A.R as well as cardiovascular preventive medicines fellowship in Asia.
About Merck Oncology Fellowship Program
The Merck Oncology Fellowship Program, a key initiative of Merck Cancer Access Program, focuses on building additional capacity through medical education and training.
The lack of financial means is not the only challenge in Africa and developing countries, but a scarcity of trained health care personnel capable to tackle the prevention, early diagnosis and management of cancer at all levels of the health care systems is even a bigger challenge.
Merck Oncology Fellowship Program focuses on building professional cancer care capacity with the aim to increase the limited number of oncologists in Africa and Developing countries. The program provides One-year fellowship program at Tata Memorial Centre - India, One and half-years Oncology Fellowship programs at University of Malaya - Malaysia, Two years Oncology Fellowship Program at University of Nairobi - Kenya and Two years Master degree in Medical Oncology at Cairo University - Egypt, in partnership with African Ministries of Health, Local Governments and Academia.
Launched in 2016, over 43 candidates from more than 21 African countries have rolled in the Merck Oncology Fellowship Program. The program will continue to build cancer care capability in African countries such as Botswana, Cameroon, CAR, Ethiopia, Gambia, Ghana, Guinea, Liberia, Mauritius, Namibia, Niger, Nigeria, Rwanda, Senegal, Tanzania, Uganda and Zambia.
About ‘Merck More Than a Mother’ campaign;
In many cultures, childless women suffer discrimination, stigma, and ostracism. Their inability to have children results in great isolation, disinheritance, and assaults. “Merck More Than a Mother” empowers such women through the access to information, health, change of mindsets and economic empowerment.
As part of this Campaign, we started “Empowering Berna” project in Africa to help childless and infertile women starting their own business and thus achieve financial independence and become stronger and happier. The project has benefited more than 1,000 women across the continent.
Also, part of the campaign is our Merck Embryology & Fertility Training Program, a three-month hands-on practical course to establish the platform of fertility specialists across Africa and Asia.
Merck Foundation provided for more than 84 candidates, three months to six months clinical and practical training for fertility specialists and embryologists in more than 29 countries across Africa and Asia such as: Chad, Niger, Central African Republic, Cote D’Ivoire , Ghana, Ethiopia , Uganda, Kenya, Tanzania , Zambia , Nigeria, Benin, Mali, Burkina Fuso, Senegal, Guinea Conakry, Sierra Leone, Liberia, Cameron, Rwanda, Botswana, DR Congo , Congo Brazzaville, Gambia , Nepal, Sri Lanka, Bangladesh, Myanmar and Cambodia.
Merck Foundation is making history in many African countries where they never had fertility specialists or specialized fertility clinics before ‘Merck More Than a Mother’ intervention, to train the first fertility specialists such as; in Sierra Leone, Liberia, The Gambia, Niger, Chad, and Guinea.
Merck Foundation plan supported the establishment of the first public IVF centers in Ethiopia and Uganda through providing the clinical and practical training necessary for their staff. Merck Foundation also plans to support the establishment of the first public IVF in Tanzania soon.
“Merck more than a Mother” launched in 2015, is a program of the Merck Foundation, the foundation drives many of our initiatives and programs in the area of build health care and research capacity and improves access to equitable healthcare solutions.
One Click on icon below to
Download Merck Foundation App
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flicker.
Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.